These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

886 related items for PubMed ID: 9002017

  • 1. Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts.
    Ichiki Y, Smith EA, LeRoy EC, Trojanowska M.
    J Rheumatol; 1997 Jan; 24(1):90-5. PubMed ID: 9002017
    [Abstract] [Full Text] [Related]

  • 2. Hypoxia regulates basal and induced DNA synthesis and collagen type I production in human cardiac fibroblasts: effects of transforming growth factor-beta1, thyroid hormone, angiotensin II and basic fibroblast growth factor.
    Agocha A, Lee HW, Eghbali-Webb M.
    J Mol Cell Cardiol; 1997 Aug; 29(8):2233-44. PubMed ID: 9281454
    [Abstract] [Full Text] [Related]

  • 3. Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors.
    Ihn H, Yamane K, Kubo M, Tamaki K.
    Arthritis Rheum; 2001 Feb; 44(2):474-80. PubMed ID: 11229480
    [Abstract] [Full Text] [Related]

  • 4. Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts.
    Ihn H, Yamane K, Asano Y, Jinnin M, Tamaki K.
    Rheumatology (Oxford); 2006 Feb; 45(2):157-65. PubMed ID: 16319104
    [Abstract] [Full Text] [Related]

  • 5. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK, Bhattacharyya S, Lakos G, Chen SJ, Mori Y, Varga J.
    Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
    [Abstract] [Full Text] [Related]

  • 6. [Basic fibroblast growth factor inhibits promoter activities of human alpha 1(I) procollagen gene induced by transforming growth factor-beta 1].
    Wan WD, Yang SL, Gao CF.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Nov; 16(6):401-3. PubMed ID: 12508433
    [Abstract] [Full Text] [Related]

  • 7. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
    Chujo S, Shirasaki F, Kawara S, Inagaki Y, Kinbara T, Inaoki M, Takigawa M, Takehara K.
    J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
    [Abstract] [Full Text] [Related]

  • 8. Collagen type I is not under autocrine control by transforming growth factor-beta 1 in normal and scleroderma fibroblasts.
    McWhirter A, Colosetti P, Rubin K, Miyazono K, Black C.
    Lab Invest; 1994 Dec; 71(6):885-94. PubMed ID: 7807970
    [Abstract] [Full Text] [Related]

  • 9. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
    Pannu J, Gore-Hyer E, Yamanaka M, Smith EA, Rubinchik S, Dong JY, Jablonska S, Blaszczyk M, Trojanowska M.
    Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
    [Abstract] [Full Text] [Related]

  • 10. Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma.
    Pannu J, Gardner H, Shearstone JR, Smith E, Trojanowska M.
    Arthritis Rheum; 2006 Sep; 54(9):3011-21. PubMed ID: 16947635
    [Abstract] [Full Text] [Related]

  • 11. Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts: association with increased expression of the type I collagen gene.
    Ihn H, Tamaki K.
    Arthritis Rheum; 2000 Oct; 43(10):2240-7. PubMed ID: 11037883
    [Abstract] [Full Text] [Related]

  • 12. Transforming growth factor-beta isoforms differently stimulate proalpha2 (I) collagen gene expression during wound healing process in transgenic mice.
    Kinbara T, Shirasaki F, Kawara S, Inagaki Y, de Crombrugghe B, Takehara K.
    J Cell Physiol; 2002 Mar; 190(3):375-81. PubMed ID: 11857453
    [Abstract] [Full Text] [Related]

  • 13. Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1.
    Yamamoto T, Eckes B, Krieg T.
    Biochem Biophys Res Commun; 2001 Feb 16; 281(1):200-5. PubMed ID: 11178980
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of the immunosuppressant FK-506 on human alpha2(I) collagen gene expression and transforming growth factor beta signaling in normal and scleroderma fibroblasts.
    Asano Y, Ihn H, Yamane K, Jinnin M, Mimura Y, Tamaki K.
    Arthritis Rheum; 2005 Apr 16; 52(4):1237-47. PubMed ID: 15818662
    [Abstract] [Full Text] [Related]

  • 15. Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators.
    Ghosh AK, Yuan W, Mori Y, Varga J.
    Oncogene; 2000 Jul 20; 19(31):3546-55. PubMed ID: 10918613
    [Abstract] [Full Text] [Related]

  • 16. Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis.
    Jelaska A, Korn JH.
    Arthritis Rheum; 2000 Oct 20; 43(10):2230-9. PubMed ID: 11037882
    [Abstract] [Full Text] [Related]

  • 17. Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor.
    Falcone DJ, McCaffrey TA, Haimovitz-Friedman A, Garcia M.
    J Cell Physiol; 1993 Jun 20; 155(3):595-605. PubMed ID: 7684044
    [Abstract] [Full Text] [Related]

  • 18. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea.
    Vuorio T, Kähäri VM, Black C, Vuorio E.
    J Rheumatol; 1991 Feb 20; 18(2):247-51. PubMed ID: 2023219
    [Abstract] [Full Text] [Related]

  • 19. Fibroblast proliferation by bleomycin stimulated peripheral blood mononuclear cell factors.
    Yamamoto T, Katayama I, Nishioka K.
    J Rheumatol; 1999 Mar 20; 26(3):609-15. PubMed ID: 10090171
    [Abstract] [Full Text] [Related]

  • 20. Fibronectin release by systemic sclerosis and normal dermal fibroblasts in response to TGF-beta.
    Xu WD, Leroy EC, Smith EA.
    J Rheumatol; 1991 Feb 20; 18(2):241-6. PubMed ID: 2023218
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.